# Kazem Rahimi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kazem-rahimi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 109,444 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 83 |
| i10-index | 181 |
| Last Known Institution | University of Oxford |
| OpenAlex ID | https://openalex.org/A5016617643 |
| ORCID iD | https://orcid.org/0000-0002-4807-4610 |
| Works | 385 |

## Researcher papers

- [2024 ESC Guidelines for the management of elevated blood pressure and hypertension](https://scholariq.org/papers/2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and/)
- [Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis](https://scholariq.org/papers/pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of/)
- [Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis](https://scholariq.org/papers/effects-of-intensive-blood-pressure-lowering-on-cardiovascular-and-renal-2/)
- [10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial](https://scholariq.org/papers/10-year-stroke-prevention-after-successful-carotid-endarterectomy-for/)
- [HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment](https://scholariq.org/papers/hps2-thrive-randomized-placebo-controlled-trial-in-25-673-high-risk-patients-of/)
- [Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden](https://scholariq.org/papers/incidence-of-heart-disease-in-35-000-women-treated-with-radiotherapy-for-breast/)
- [Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013](https://scholariq.org/papers/changes-in-health-in-england-with-analysis-by-english-regions-and-areas-of/)
- [Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis](https://scholariq.org/papers/age-stratified-and-blood-pressure-stratified-effects-of-blood-pressure-lowering/)
- [2025 ESC Guidelines for the management of myocarditis and pericarditis](https://scholariq.org/papers/2025-esc-guidelines-for-the-management-of-myocarditis-and-pericarditis/)
- [Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life](https://scholariq.org/papers/effect-of-digoxin-vs-bisoprolol-for-heart-rate-control-in-atrial-fibrillation-on/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Machine Learning in Healthcare](https://scholariq.org/topics/machine-learning-in-healthcare/)
- [Chronic Disease Management Strategies](https://scholariq.org/topics/chronic-disease-management-strategies/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Researcher university

- [University of Oxford](https://scholariq.org/institutions/university-of-oxford/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.